Given that IFN-γ is a widely distributed cytokine produced in response to anti-PD-L1 therapy (22), we validated its capability to inhibit the expression of ANGPT2 and Tie2 in ECs and reduce the expression of VEGF-A in tumor cells. The gene discussed is ANGPT2; the disease is neoplasm.